日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

End-to-end application of model-informed drug development for ertugliflozin, a novel sodium-glucose cotransporter 2 inhibitor

将基于模型的药物开发方法应用于新型钠-葡萄糖协同转运蛋白2抑制剂ertugliflozin的端到端开发

Fediuk, Daryl J; Nucci, Gianluca; Dawra, Vikas K; Callegari, Ernesto; Zhou, Susan; Musante, Cynthia J; Liang, Yali; Sweeney, Kevin; Sahasrabudhe, Vaishali

Population pharmacokinetics and exposure-response analyses of varenicline in adolescent smokers

伐尼克兰在青少年吸烟者中的群体药代动力学和暴露-反应分析

Fediuk, Daryl J; Sweeney, Kevin; Sahasrabudhe, Vaishali; McRae, Thomas; Byon, Wonkyung

Meta-Analysis of Noncompartmental Pharmacokinetic Parameters of Ertugliflozin to Evaluate Dose Proportionality and UGT1A9 Polymorphism Effect on Exposure.

对 Ertugliflozin 非房室药代动力学参数进行荟萃分析,以评估剂量比例性和 UGT1A9 多态性对暴露的影响

Marshall Jean-Claude, Liang Yali, Sahasrabudhe Vaishali, Tensfeldt Thomas, Fediuk Daryl J, Zhou Susan, Krishna Rajesh, Dawra Vikas Kumar, Wood Linda S, Sweeney Kevin

Effect of Food on the Pharmacokinetics of Ertugliflozin and Its Fixed-Dose Combinations Ertugliflozin/Sitagliptin and Ertugliflozin/Metformin

食物对厄格列净及其固定剂量复方制剂(厄格列净/西格列汀和厄格列净/二甲双胍)药代动力学的影响

Sahasrabudhe, Vaishali; Fediuk, Daryl J; Matschke, Kyle; Shi, Haihong; Liang, Yali; Hickman, Anne; Bass, Almasa; Terra, Steven G; Zhou, Susan; Krishna, Rajesh; Dawra, Vikas K

Bioequivalence of Ertugliflozin/Sitagliptin Fixed-Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components

艾格列净/西格列汀固定剂量复方片剂的生物等效性及其各组分不同规格联合用药的生物等效性

Fediuk, Daryl J; Matschke, Kyle; Liang, Yali; Pelletier, Kathleen B; Wei, Hua; Shi, Haihong; Bass, Almasa; Hickman, Anne; Terra, Steven G; Zhou, Susan; Krishna, Rajesh; Sahasrabudhe, Vaishali